showed a trendp =0.074
15.4%, p =0.034) and showed a trend toward longer OS (2-year, 100% vs . 84.6%, p =0.074) than patients who had other metastatic diseases.
15.4%, p =0.034) and showed a trend toward longer OS (2-year, 100% vs . 84.6%, p =0.074) than patients who had other metastatic diseases.